Minutes from Annual General meeting 2026
23 april, 10:58
23 april, 10:58
The Annual General Meeting (AGM) of Lifecare ASA was held today as a hybrid meeting. All proposals on the agenda were adopted, cf. the notice of the AGM that was published on Oslo Stock Exchange on April 1, 2026.
The minutes are attached and available at https://lifecare.no/investor/governance.
The AGM elected three new directors to the Board: Tore B. Ellingsen, Kathrine Gamborg Andreassen and Renete Kaarvik, all for a period of two years.
The Board of Lifecare ASA thus consists of the following directors:
About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Petter Nielsen, CFO, petter.nielsen@lifecare.no, +47 92 24 74 64
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-23 10:58 CEST.
23 april, 10:58
The Annual General Meeting (AGM) of Lifecare ASA was held today as a hybrid meeting. All proposals on the agenda were adopted, cf. the notice of the AGM that was published on Oslo Stock Exchange on April 1, 2026.
The minutes are attached and available at https://lifecare.no/investor/governance.
The AGM elected three new directors to the Board: Tore B. Ellingsen, Kathrine Gamborg Andreassen and Renete Kaarvik, all for a period of two years.
The Board of Lifecare ASA thus consists of the following directors:
About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Petter Nielsen, CFO, petter.nielsen@lifecare.no, +47 92 24 74 64
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-23 10:58 CEST.
Investmentbolag
Privatekonomi
Telias sparpaket
Investmentbolag
Privatekonomi
Telias sparpaket
1 DAG %
Senast
OMX Stockholm 30
0,26%
(14:47)
Citigroup
Idag, 14:17
Citigroups vinst högre än väntat
sparande
Idag, 14:12
Här får du bäst ränta på sparkontot
Nokia
Idag, 14:00
AI-press på telekombolagen
OMX Stockholm 30
1 DAG %
Senast
3 278,68